Entry |
|
Name |
NNK/NNN to PI3K signaling pathway
|
Definition |
(NNK,NNN) -> CHRNA7 -> Ca2+ -> PI3K -> PIP3 -> AKT -> (MTOR,NFKB,BIRC5) |
Expanded |
(C16453,C16452) -> 1139 -> C00076 -> (5290,5291,5293) -> C05981 -> (207,208,10000) -> (2475,(4790+5970),332) |
Class |
|
Type |
Env factor
|
Pathway |
hsa05207 | Chemical carcinogenesis - receptor activation |
|
Disease |
H00014 | Non-small cell lung cancer |
|
Gene |
1139 | CHRNA7; cholinergic receptor nicotinic alpha 7 subunit |
5290 | PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5291 | PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5293 | PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
207 | AKT1; AKT serine/threonine kinase 1 |
208 | AKT2; AKT serine/threonine kinase 2 |
10000 | AKT3; AKT serine/threonine kinase 3 |
2475 | MTOR; mechanistic target of rapamycin kinase |
4790 | NFKB1; nuclear factor kappa B subunit 1 |
5970 | RELA; RELA proto-oncogene, NF-kB subunit |
332 | BIRC5; baculoviral IAP repeat containing 5 |
|
Perturbant |
C16453 (NNK) | 4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone |
C16452 (NNN) | N'-Nitrosonornicotine |
|
Metabolite |
C05981 | Phosphatidylinositol-3,4,5-trisphosphate |
|
Reference |
|
Authors |
Wen J, Fu JH, Zhang W, Guo M |
Title |
Lung carcinoma signaling pathways activated by smoking. |
Journal |
|
Reference |
|
Authors |
Improgo MR, Tapper AR, Gardner PD |
Title |
Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer. |
Journal |
|
Reference |
|
Authors |
Wu CH, Lee CH, Ho YS |
Title |
Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy. |
Journal |
|
LinkDB |
|